Financial toxicity in cancer care in India: a systematic review

Lancet Oncol. 2021 Dec;22(12):e541-e549. doi: 10.1016/S1470-2045(21)00468-X.

Abstract

Although financial toxicity is widely acknowledged to be a potential consequence of costly cancer treatment, little is known about its prevalence and outcome among the Indian population. In this study, we systematically reviewed the prevalence, determinants, and consequences of financial toxicity among patients with cancer in India. 22 studies were included in the systematic review. The determinants of financial toxicity include household income, type of health-care facility used, stage of disease, area of residence, age at the time of diagnosis, recurrent cancer, educational status, insurance coverage, and treatment modality. Financial toxicity was associated with poor quality of life, accumulation of debts, premature entry into the labour market, and non-compliance with therapy. Our findings emphasise the need for urgent strategies to mitigate financial toxicity among patients with cancer in India, especially in the most deprived sections of society. The qualitative evidence synthesised in this systematic review could provide a basis for the development of such interventions to reduce financial toxicity among patients with cancer.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Financial Stress / epidemiology*
  • Humans
  • India / epidemiology
  • Insurance Coverage / economics*
  • Insurance Coverage / statistics & numerical data
  • Insurance, Health / economics*
  • Insurance, Health / statistics & numerical data
  • Neoplasms / economics*
  • Neoplasms / epidemiology
  • Neoplasms / therapy*
  • Patient Care / economics*
  • Quality of Life